Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis

Mol Cell Biol. 2006 Mar;26(6):2215-25. doi: 10.1128/MCB.26.6.2215-2225.2006.

Abstract

Receptor-interacting protein (RIP) has been implicated in the induction of death receptor-mediated, nonapoptotic cell death. However, the mechanisms remain to be elucidated. Here we show that tumor necrosis factor alpha induced RIP-dependent inhibition of adenine nucleotide translocase (ANT)-conducted transport of ADP into mitochondria, which resulted in reduced ATP and necrotic cell death. The inhibition of ADP/ATP exchange coincided with the loss of interaction between ANT and cyclophilin D and the inability of ANT to adopt the cytosolic conformational state, which prevented cytochrome c release. Neither overexpression of Bcl-xL nor inhibition of reactive oxygen species prevented necrosis. In contrast, the ectopic expression of ANT or cyclophilin D was effective at preventing cell death. These observations demonstrate a novel mechanism initiated through death receptor ligation and mediated by RIP that results in the suppression of ANT activity and necrosis.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenosine Diphosphate / metabolism*
  • Adenosine Triphosphate / metabolism*
  • Amino Acid Chloromethyl Ketones / metabolism
  • Amino Acid Chloromethyl Ketones / pharmacology
  • Biological Transport / drug effects
  • Cell Death / drug effects
  • Cell Death / physiology
  • Cells, Cultured
  • Cyclophilins / pharmacology
  • Cysteine / metabolism
  • Cysteine Proteinase Inhibitors / metabolism
  • Cysteine Proteinase Inhibitors / pharmacology
  • Humans
  • Intracellular Membranes
  • Membrane Potentials / drug effects
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Mitochondrial ADP, ATP Translocases / drug effects
  • Mitochondrial ADP, ATP Translocases / genetics
  • Mitochondrial ADP, ATP Translocases / metabolism
  • Necrosis*
  • Peptidyl-Prolyl Isomerase F
  • Permeability
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • Reactive Oxygen Species / metabolism
  • Receptor-Interacting Protein Serine-Threonine Kinases
  • Tumor Necrosis Factor Receptor-Associated Peptides and Proteins / antagonists & inhibitors
  • Tumor Necrosis Factor Receptor-Associated Peptides and Proteins / genetics
  • Tumor Necrosis Factor Receptor-Associated Peptides and Proteins / metabolism*
  • Tumor Necrosis Factor-alpha / pharmacology
  • bcl-X Protein / genetics
  • bcl-X Protein / metabolism

Substances

  • Amino Acid Chloromethyl Ketones
  • BCL2L1 protein, human
  • Peptidyl-Prolyl Isomerase F
  • Cysteine Proteinase Inhibitors
  • Reactive Oxygen Species
  • Tumor Necrosis Factor Receptor-Associated Peptides and Proteins
  • Tumor Necrosis Factor-alpha
  • bcl-X Protein
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • Adenosine Diphosphate
  • Adenosine Triphosphate
  • Mitochondrial ADP, ATP Translocases
  • Protein Serine-Threonine Kinases
  • RIPK1 protein, human
  • Receptor-Interacting Protein Serine-Threonine Kinases
  • Cyclophilins
  • Cysteine